AstraZeneca, Novavax ready to team up with SII for mass jab production
Located in the city of Pune in Maharashtra, the SII is the world s largest vaccine manufacturer by volume
PTI | February 25, 2021 | Updated 08:06 IST
Covishield is less expensive compared to some of the other vaccines being used such as the ones from Pfizer-BioNTech and Moderna
British-Swedish pharma giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
Located in the city of Pune in Maharashtra, the SII is the world s largest vaccine manufacturer by volume.
Serum expected a decision on an Indian trial of Novavax s vaccine soon, Chief Executive Adar Poonawalla said, hours after the US company reported the efficacy data